RECENT ARTICLES
South Africa to pay $5.25 a dose for AstraZeneca vaccine from India's SII
By JOHANNESBURG (Reuters) - South Africa will pay $5.25 per dose for 1.5 million shots of AstraZeneca’s coronavirus vaccine from the Serum Institute of India (SII), a senior official said on Thursday, more than some wealthier countries are paying.Health department Deputy Director-General Anban Pillay told Reuters that SII’s price was based on South Africa’s status as an upper-middle-income country under a World Bank classification.The price is higher than the $3 a dose that South Africa and other countries on the continent are due to pay for the same vaccine under an African Union (AU)...…By JOHANNESBURG (Reuters) - South Africa will pay $5.25 per dose for 1.5 million shots of AstraZeneca’s coronavirus vaccine from the Serum Institute of India (SII), a senior official said on Thursday, more than some wealthier countries are paying.Health department Deputy Director-General Anban Pillay told Reuters that SII’s price was based on South Africa’s status as an upper-middle-income country under a World Bank classification.The price is higher than the $3 a dose that South Africa and other countries on the continent are due to pay for the same vaccine under an African Union (AU)...WW…
Previous coronavirus infection may offer less protection from new variant
By , JOHANNESBURG (Reuters) - Previous infection with the coronavirus may offer less protection against the new variant first identified in South Africa, scientists said on Monday, although they hope that vaccines will still work.Studies also found that the new variant binds more strongly and readily to human cells. That helps explain why it seems to be spreading around 50% quicker than previous versions, leading South African epidemiologist Salim Abdool Karim said.The 501Y.V2 variant was identified by South African genomics experts late last year. It has been the main driver of a second...…By , JOHANNESBURG (Reuters) - Previous infection with the coronavirus may offer less protection against the new variant first identified in South Africa, scientists said on Monday, although they hope that vaccines will still work.Studies also found that the new variant binds more strongly and readily to human cells. That helps explain why it seems to be spreading around 50% quicker than previous versions, leading South African epidemiologist Salim Abdool Karim said.The 501Y.V2 variant was identified by South African genomics experts late last year. It has been the main driver of a second...WW…
South African variant unlikely to 'completely negate' COVID vaccines, scientist says
By JOHANNESBURG (Reuters) - A variant of the coronavirus first detected in South Africa is unlikely to completely negate the immunising effects of vaccines, a researcher studying it told Reuters.British scientists expressed concern on Monday that COVID-19 vaccines may not be able to protect against the variant identified by South African scientists and which has spread internationally.Richard Lessells, an infectious disease expert at the KwaZulu-Natal Research Innovation and Sequencing Platform, which played a central role in identifying the variant known as 501Y.V2, said his understanding...…By JOHANNESBURG (Reuters) - A variant of the coronavirus first detected in South Africa is unlikely to completely negate the immunising effects of vaccines, a researcher studying it told Reuters.British scientists expressed concern on Monday that COVID-19 vaccines may not be able to protect against the variant identified by South African scientists and which has spread internationally.Richard Lessells, an infectious disease expert at the KwaZulu-Natal Research Innovation and Sequencing Platform, which played a central role in identifying the variant known as 501Y.V2, said his understanding...WW…
- Total 3 items
- 1